Clinical Trial Update: Comparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre Syndrome [NA]

View source ↗

Summary

A clinical trial compares immunoadsorption and intravenous immunoglobulin for Guillain-Barré syndrome, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Guillain-barré Syndrome

Drugs mentioned

• Immunoadsorption
• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: The First Affiliated Hospital of Zhengzhou University | Conditions: Guillain-Barre Syndrome | NA | Status: NOT_YET_RECRUITING